Is Sanofi Consumer Healthcare India Ltd. a good investment? Sanofi Consumer Healthcare India Ltd. (SANOFICONR.NS) is currently trading at 3752.70 INR.
In terms of valuation, the stock trades at a P/E ratio of 32.89. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Sanofi Consumer Healthcare India Ltd. is expected to release its next earnings report on Nov. 18, 2026. The market consensus estimate for Forward EPS is 133.90.
For income investors, Sanofi Consumer Healthcare India Ltd. pays a dividend yield of 1.87%. With a payout ratio of 48%, the dividend appears sustainable.
Yes, it pays an annual dividend of 75.00 INR (1.87% yield).
Sanofi Consumer Healthcare India Ltd. is classified as a Stock.
The next earnings date is projected to be Nov. 18, 2026. The company currently has a trailing EPS of 115.62.
Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India. The company offers products in the allergy, physical wellness, and pain care segments under Allegra, Combiflam, Avil, DePURA, Festal, and other brand names through distributors, wholesalers, government institutions and hospitals, pharmacy chains, and e-commerce platforms. The company was incorporated in 2023 and is based in Mumbai, India. Sanofi Consumer Healthcare India Limited operates as a subsidiary of Opella Healthcare Participations B.V.
| Year | Total Dividends |
|---|---|
| ▸2027 |
75.00 INR
|
| July 9, 2027 (estimated) | 75.0000 |
| ▸2026 |
75.00 INR
|
| July 9, 2026 | 75.0000 |
| ▸2025 |
55.00 INR
|
| May 20, 2025 | 55.0000 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Sanofi Consumer Healthcare India Ltd. | Jul 09, 2026 | Paid | 75.0 INR |
Community Discussion